Drug
Pridopidine
Pridopidine: highest development phase Phase 3, developed by Ferrer. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Ferrer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Pridopidine NCT07322003 | Phase 3 | Amyotrophic Lateral Sclerosis |
| Pridopidine NCT07609108 | Phase 3 | Huntington Disease |
Latest
No recent events.
Follow Pridopidine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.